[Viral infections in intravenous drug addicts. Clinical and prognostic significance]. 1991

H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
Unidade de Hepatologia e Centro de Gastrenterologia (INIC), Hospital de Santa Maria, Lisboa.

A retrospective analysis of 135 drug addicts followed between 1986 to 1987, was done, in order to asses the seroprevalence of hepatitis B virus (HBV), hepatitis Delta virus (HDV), hepatitis C virus (HCV) and Human Immunodeficiency virus (HIV), as also their clinical and prognostic significance. A high prevalence of HBV, HDV and HCV infection was observed in this study: 81%, 64% and 83% respectively; in contrast just one case was positive for HIV. Among the drug addicts the frequency of multiple infections (HBV/HCV 51.6%; HBV/HDV/HCV 18.7%; HBV/HDV 2.2%; HCV/HIV 1.1%) was highest in comparison with isolated (HBV 5.5%; HCV 12.1%) or absent infection (73.6% vs 17.6% vs 8.8% respectively; p less than 0.001). Eleven of 12 (92%) patients with Delta hepatitis and HCV superinfection were seronegative for IgM anti-HD; in contrast the case without HCV superinfection was IgM anti-HD positive. In the former group the Alanine Amino-transferases (ALT) were significantly lower comparatively with those HBV positive patients superinfected by HCV (97 +/- 92 IU/L vs 249 +/- 125 IU/L; p = 0.001), and were not different from drug addicts with isolated HCV infection (62 +/- 49 IU/L). The results of this study indicate, a low prevalence of HIV infection in the Portuguese drug addicts and a high frequency of multiple HBV, HDV and HCV infection in the same period of study. Our observations suggest that HCV may have the capacity to inhibit the replication and pathogenic activity of hepatitis Delta virus.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
May 1985, AJR. American journal of roentgenology,
H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
May 1999, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
June 1994, European journal of epidemiology,
H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
September 1999, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
August 1984, La Clinica terapeutica,
H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
September 1988, Anales de medicina interna (Madrid, Spain : 1984),
H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
July 1971, Postgraduate medical journal,
H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
June 1987, European journal of epidemiology,
H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
August 1985, Schweizerische medizinische Wochenschrift,
H Glória, and F Ramalho, and R Marinho, and M Pedro, and J Velosa, and M C Moura
July 1980, World journal of surgery,
Copied contents to your clipboard!